iShares Biotechnology ETF
IBB
IBB
649 hedge funds and large institutions have $4.6B invested in iShares Biotechnology ETF in 2018 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 154 increasing their positions, 253 reducing their positions, and 83 closing their positions.
Holders
649
Holders Change
+18
Holders Change %
+2.85%
% of All Funds
14.48%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.4%
New
112
Increased
154
Reduced
253
Closed
83
Calls
$321M
Puts
$610M
Net Calls
-$289M
Net Calls Change
-$13.4M
Top Buyers
Top Sellers
1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$48.7M |
2 |
2
Citigroup
New York
|
$118M |
3 |
3
Bank of America
Charlotte,
North Carolina
|
$1.26B |
4 |
DFO
4
Duquesne Family Office
New York
|
$33.8M |
5 |
5
Goldman Sachs
New York
|
$146M |